Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA (FSNUY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
fsnuy · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Fresenius SE & Co. KGaA (FSNUY) measures how much investors pay for each dollar of the company's trailing earnings. FSNUY's current PE ratio of 14.09x is calculated by dividing its stock price of $10.65 by its TTM earnings per share of $2.62. −75.4% discount vs 5Y avg 57.2x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%19.8x
MedianQ3 · 75%161.7x
Max
At 14.09x, FSNUY's current P/E is within its average historical range over the past 19 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Fresenius SE & Co. KGaAYou FSNUY | $96.0B | 14.09x | -60.3% | $2.62 |
 AstraZeneca PLC AZNCF | $294.4B | 26.60x | -25.1% | $6.60 |
 CSL Limited CSLLY | $66.3B | 51.08x | +43.8% | $0.78 |
 EssilorLuxottica S.A. ESLOF | $92.4B | 53.83x | +51.6% | $5.04 |
 EssilorLuxottica S.A. ESLOY | $91.8B | 55.67x | +56.7% | $2.42 |
 Fresenius Medical Care AG & Co. KGaA FMCQF | $11.6B | 11.79x | -66.8% | $3.36 |
 Novo Nordisk A/S NONOF | $183.3B | 14.11x | -60.3% | $23.00 |
Industry Average 6 peers with valid PE | — | 35.51x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 90.53x | $0.13 | -44.0% | |
2024-12-31 FY2024 | 161.67x | $0.05 | — | |
2023-12-31 FY2023 | — | $-0.07 | — | |
2022-12-31 FY2022 | 10.68x | $0.61 | -0.9% | |
2021-12-31 FY2021 | 10.78x | $0.81 | -13.5% | |
2020-12-31 FY2020 | 12.45x | $0.77 | -15.4% | |
2019-12-31 FY2019 | 14.72x | $0.85 | +26.5% | |
2018-12-31 FY2018 | 11.64x | $0.91 | -41.3% | |
2017-12-31 FY2017 | 19.83x | $0.82 | -22.0% | |
2016-12-31 FY2016 | 25.43x | $0.73 | -3.6% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Fresenius SE & Co. KGaA (FSNUY) measures how much investors pay for each dollar of the company's trailing earnings. FSNUY's current PE ratio of 14.09x is calculated by dividing its stock price of $10.65 by its TTM earnings per share of $2.62.
Frequently asked questions
FSNUY pe ratio · 6 questionsFSNUY's current PE ratio is 14.09x as of 2026-06-09, based on a stock price of $10.65 and TTM EPS of $2.62. Data sourced from Financial Modeling Prep via FSNUY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Fresenius SE & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09